Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary

被引：0
|
作者：
Abou-Taleb, H. [1 ]
Yamaguchi, K. [1 ]
Mandai, M. [1 ]
Amano, Y. [1 ]
Kosaka, K. [1 ]
Matsumura, N. [1 ]
Baba, T. [1 ]
Yoshioka, Y. [1 ]
Hamanishi, J. [1 ]
Konishi, I [1 ]
机构：
[1] Kyoto Univ Shogoin, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, Kyoto, Japan
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2012年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [1] HNF1β Expression and Loss of ARID1A Correlate with Histological Component in Uterine Carcinosarcomas
    Ferreira, Joana
    Luz, Rita
    Silva, Fernanda
    Felix, Ana
    LABORATORY INVESTIGATION, 2016, 96 : 283A - 283A
  • [2] HNF1β Expression and Loss of ARID1A Correlate with Histological Component in Uterine Carcinosarcomas
    Ferreira, Joana
    Luz, Rita
    Silva, Fernando
    Felix, Ana
    MODERN PATHOLOGY, 2016, 29 : 283A - 283A
  • [3] HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma
    Amano, Yasuaki
    Yamaguchi, Ken
    Mandai, Masaki
    Matsumura, Noriomi
    Hamanishi, Junzo
    Baba, Tsukasa
    Yamanoi, Koji
    Murphy, Susan K.
    Konishi, Ikuo
    CLINICAL CANCER RESEARCH, 2013, 19
  • [4] Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes
    Tsunematsu, Risa
    Murai, Aiko
    Mizue, Yuka
    Kubo, Terufumi
    Mariya, Tasuku
    Morita, Rena
    Murata, Kenji
    Kanaseki, Takayuki
    Tsukahara, Tomohide
    Hirohashi, Yoshihiko
    Saito, Tsuyoshi
    Torigoe, Toshihiko
    CANCER GENOMICS & PROTEOMICS, 2024, 21 (04) : 414 - 420
  • [5] ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component
    Nishikimi, Kyoko
    Kiyokawa, Takako
    Tate, Shinichi
    Iwamoto, Masami
    Shozu, Makio
    HISTOPATHOLOGY, 2015, 67 (06) : 866 - 871
  • [6] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    MODERN PATHOLOGY, 2011, 24 : 259A - 259A
  • [7] BAF250a (ARID1A) Combined with HNF-1b, ER and P53 Can Distinguish between Ovarian Clear Cell Carcinoma and Papillary Serous Carcinoma
    Xiao, W.
    Awadallah, A.
    Xin, W.
    MODERN PATHOLOGY, 2012, 25 : 301A - 301A
  • [8] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma.
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    LABORATORY INVESTIGATION, 2011, 91 : 259A - 259A
  • [9] Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, Daichi
    Mao, Tsui-Lien
    Fukayama, Masashi
    Nakagawa, Shunsuke
    Yano, Tetsu
    Taketani, Yuji
    Shih, Ie-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (12): : 5121 - 5129
  • [10] ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
    Caumanns, Joseph J.
    Wisman, G. Bea A.
    Berns, Katrien
    van der Zee, Ate G. J.
    de Jong, Steven
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 176 - 184
12345